Vijay Nambi

机构：Michael E. DeBakey VA Medical Center, Baylor College of Medicine, Baylor School · ORCID：0000-0002-4237-0267

发表论文 656 篇 · 总被引 16646 次 · h-index 62

代表论文

• 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines (2026 · Circulation · 被引 67)
• Liberal or Restrictive Postoperative Transfusion in Patients at High Cardiac Risk (2025 · JAMA · 被引 11)
• Association between Oral Beta Blocker Therapy and long-term Outcomes after Myocardial Infarction in Individuals with Mildly Reduced or Preserved Left Ventricular Function – a Meta-Analysis of Contemporary Randomized Controlled Trials (2025 · Cardiovascular Drugs and Therapy · 被引 3)
• Socioeconomic Correlates of Incident Heart Failure and Consequent Mortality (2026 · JACC Heart Failure · 被引 1)
• Metformin added to lifestyle intervention for physical function in older adults with obesity (DEMFOS trial): a randomised controlled trial (2026 · The Lancet Healthy Longevity)
• Projected impact of 2026 ACC/AHA/Multisociety Dyslipidemia Guideline on lipid-lowering therapy eligibility based on Class 1 and 2a recommendations (2026 · Journal of clinical lipidology)